Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Tourette Syndrome
NCT00206336Phase 3Completed
- Sponsor
- Baylor College of Medicine
- Start
- Oct 2004
- Primary completion
- Dec 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in Tourette syndrome (TS), sponsored by Baylor College of Medicine. Started Oct 2004; status: completed.
02
Drugs
topiramate
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT00206336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206336.